Literature DB >> 3510311

Hepatitis B virus polypeptide X: expression in Escherichia coli and identification of specific antibodies in sera from hepatitis B virus-infected humans.

M L Meyers, L V Trepo, N Nath, J J Sninsky.   

Abstract

Sequence analysis of the hepatitis B virus (HBV) genome revealed the presence of an open reading frame (ORF X) which has the potential to encode a 154-amino acid polypeptide. A fusion protein containing 145 of the amino acids encoded by ORF X and 8 amino acids of beta-galactosidase was expressed and characterized in bacterial extracts. Immunoprecipitations with the ORF X fusion protein as a radioactively labeled antigen were performed to screen sera of humans infected with HBV for the presence of antibodies against ORF X-encoded determinants (anti-X). Such antibodies were identified in 9 samples from a set of 26 sera characterized as positive for HBV surface antigen but were not found in 16 normal human sera. The data reported here demonstrate that sera from some patients with markers of HBV infection contain antibodies directed against the polypeptide encoded by ORF X. As such, these findings represent evidence that ORF X constitutes a gene, or a portion of a gene, which is expressed during HBV infection. Although there does not appear to be a direct relationship between anti-X and any individual markers of HBV infection, our data suggest that anti-X is more prevalent in HBV-positive sera containing antibodies to HBe3 antigen (anti-HBe3).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510311      PMCID: PMC252703     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Chain length determination of small double- and single-stranded DNA molecules by polyacrylamide gel electrophoresis.

Authors:  T Maniatis; A Jeffrey; H van deSande
Journal:  Biochemistry       Date:  1975-08-26       Impact factor: 3.162

Review 2.  In vitro synthesis of protein in microbial systems.

Authors:  G Zubay
Journal:  Annu Rev Genet       Date:  1973       Impact factor: 16.830

Review 3.  Pedigrees of some mutant strains of Escherichia coli K-12.

Authors:  B J Bachmann
Journal:  Bacteriol Rev       Date:  1972-12

4.  The chromosome of bacteriophage T5. I. Analysis of the single-stranded DNA fragments by agarose gel electrophoresis.

Authors:  G S Hayward; M G Smith
Journal:  J Mol Biol       Date:  1972-02-14       Impact factor: 5.469

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma.

Authors:  A M Moriarty; H Alexander; R A Lerner; G B Thornton
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

7.  Cloning and analysis of integrated hepatitis virus sequences from a human hepatoma cell line.

Authors:  Y Shaul; M Ziemer; P D Garcia; R Crawford; H Hsu; P Valenzuela; W J Rutter
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

8.  Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat.

Authors:  A Dejean; P Sonigo; S Wain-Hobson; P Tiollais
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

9.  Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA.

Authors:  S N Cohen; A C Chang; L Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

10.  Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization.

Authors:  M Kobayashi; K Koike
Journal:  Gene       Date:  1984-10       Impact factor: 3.688

View more
  20 in total

1.  Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters.

Authors:  L Kwee; R Lucito; B Aufiero; R J Schneider
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Transcriptional trans-activating function of hepatitis B virus.

Authors:  J S Twu; R H Schloemer
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

Review 3.  Viral hepatitis.

Authors:  J Y Lau; G J Alexander; A Alberti
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

4.  Antibodies to pre-S and X determinants arise during natural infection with ground squirrel hepatitis virus.

Authors:  D H Persing; H E Varmus; D Ganem
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

5.  X-region-specific transcript in mammalian hepatitis B virus-infected liver.

Authors:  S Kaneko; R H Miller
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

6.  Antibodies to hepatitis B virus x-protein in sera of patients with acute and chronic active hepatitis.

Authors:  R Abraham; H W Doerr; W Braun; M Stemler; H Will; G Hess; C H Schröder
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

7.  Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication.

Authors:  R Colgrove; G Simon; D Ganem
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

8.  Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice.

Authors:  T H Lee; M J Finegold; R F Shen; J L DeMayo; S L Woo; J S Butel
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

9.  Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma.

Authors:  Guang-Yuh Hwang; Chuang-Yu Lin; Li-Mei Huang; Yan-Hsiung Wang; Jing-Chyi Wang; Ching-Ting Hsu; Sheng-Shun Yang; Cheng-Chung Wu
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

10.  Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2.

Authors:  M Levrero; C Balsano; G Natoli; M L Avantaggiati; E Elfassi
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.